Name | Value |
---|---|
Revenues | 97.4M |
Cost of Revenue | 38.4M |
Gross Profit | 59.1M |
Operating Expense | 33.8M |
Operating I/L | 25.3M |
Other Income/Expense | -12.5M |
Interest Income | 0.4M |
Pretax | 12.8M |
Income Tax Expense | 5.2M |
Net Income/Loss | 7.5M |
Artivion Inc. is a global manufacturer and distributor of medical devices and implantable human tissues. The company's product portfolio includes BioGlue, cardiac preservation services, vascular grafts, hemostats, prosthetic heart valves, stent graft systems, and synthetic vascular grafts. Artivion serves physicians, hospitals, and healthcare facilities, offering a wide range of products for cardiac, vascular, neurologic, and pulmonary procedures. The company generates revenue through the sale of its medical devices and tissues to healthcare providers and surgeons worldwide.